Comparison Between Cystatin C and Beta-2-Microglobulin as New Serum Biomarkers of Renal Disease in Dogs
World Small Animal Veterinary Association World Congress Proceedings, 2015
L. Navarro; M.T. Verde; M. Pardo; S. Villanueva; C. Ferreira
Animal Medicine, University of Zaragoza, Zaragoza, Spain

Introduction

There are few techniques available to detect the early impairment of renal function in a cost-effective and easy methodology. Some molecules that have been recently advocated for in the diagnosis of kidney disease in humans, have also been tested in dogs with renal disease, showing promising results.

Objectives

The aim of the present study was to evaluate two new serum markers, beta-2-microglobulin (B2M) and cystatin C (CysC), for the diagnosis of renal diseases in dogs.

Methods

A total of 75 dogs were included and classified in groups depending on the pathology: CKD (20), urinary tract pathologies other than CKD (18), leishmaniasis (16) and systemic diseases (21). Twenty healthy dogs were in the control population.

Retrospective analysis of serum and urine samples collected was performed. Serum levels of CysC (sCysC) and B2M (sB2M) were determinate with a particle-enhanced immunoturbidimetric assay (PETIA) method. Results were correlated with serum creatinine (sCr), BUN, phosphorus concentrations (P) and urinary protein-to-creatinine ratio (UPC); and compared between groups.

Results

All serum biomarkers, except B2M, distinguished dogs with renal disease from normal dogs (p < 0,001) and/or dogs with other diseases (p < 0,01). In dogs with evidences of renal damage, sCysC correlated most strongly with sCr (r = 0,69), P (r = 0,79) and UPC (r = 0,83), (p < 0,05). However, B2M was not correlated with other biomarkers.

Conclusion

sCysC showed to be more specific and sensible to detect kidney damage than B2M; consequently, sCysC would be more useful in the application of future protocols for diagnosis of renal diseases in dogs.

  

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

L. Navarro
Animal Medicine
University of Zaragoza
Zaragoza, Spain


MAIN : Critical Care & Emergency Medicine : Cystatin C & Beta-2-Microglobulin
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27